The last frontier: transcatheter devices for percutaneous or minimally invasive treatment of chronic heart failure

Nijenhuis, Vincent J.; Sanchís, Laura; Heyden, Jan A.S. Van der; Klein, Patrick; Rensing, Benno J.; Latib, Azeem; Berg, J. M. ten; Agostoni, P.; Swaans, Martin J.

doi:10.1007/s12471-017-1018-8

Cited by 9 publications

(8 citation statements)

References 47 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Considering the safety and effectiveness of static ballooning for creating a restrictive ASD, the indication of such an interventional procedure should be expanded and pathophysiologically driven and not by the availability of any devices to regulate inter-atrial flows, which are just lunched on the market [6].…”

Section: Resultsmentioning

confidence: 99%

Transcatheter Decompression of the Left Atrium in an Adolescent with a Double Inlet Left Ventricle, Severe Parachute Mitral Valve Stenosis and Pulmonary Hypertension

Cai¹,

Li²,

Li³

et al. 2017

WJCD

View full text Add to dashboard Cite

A 17-year-old adolescent with non-operated double inlet left-ventricle and severe stenosed parachute mitral valve is reported. He was admitted with repetitive syncope related to intermittent atrial fibrillation. Life-threatening syncope combined with pre-and post-capillary pulmonary hypertension together with his single ventricle pathophysiology led to the decision for left atrial decompression by percutaneous static atrial septum ballooning after transseptal needle perforation. Aiming to create a restrictive atrial septum defect, unloading of the left atrium without disturbing the balanced hemodynamics was directed for a long-term palliation or as a basis for a further surgical follow-up approach.

show abstract

Section: Resultsmentioning

confidence: 99%

Transcatheter Decompression of the Left Atrium in an Adolescent with a Double Inlet Left Ventricle, Severe Parachute Mitral Valve Stenosis and Pulmonary Hypertension

Cai¹,

Li²,

Li³

et al. 2017

WJCD

View full text Add to dashboard Cite

show abstract

“…28,29 This imbalance contributes to the progression of HF and associates with poor outcomes. [28][29][30] Increasing parasympathetic tone by cervical vagus nerve stimulation (cVNS) showed a beneficial effect on cardiac function and improved long-term survival in rats with HF. 31 This and other preclinical studies 32 opened the door to study the effect of cVNS in patients with HF.…”

Section: Cervical Vagal Nerve Stimulationmentioning

confidence: 99%

Neuromodulation interventions in the management of heart failure

Abdin,

Lauder,

Fudim

et al. 2024

European J of Heart Fail

View full text Add to dashboard Cite

Despite remarkable improvements in the management of heart failure (HF), HF remains one of the most rapidly growing cardiovascular condition resulting in a substantial burden on healthcare systems worldwide. In clinical practice, however, a relevant proportion of patients are treated with suboptimal combinations and doses lower than those recommended in the current guidelines. Against this background, it remains important to identify new targets and investigate additional therapeutic options to alleviate symptoms and potentially improve prognosis in HF. Therefore, non‐pharmacological interventions targeting autonomic imbalance in HF have been evaluated. This paper aims to review the physiology, available clinical data, and potential therapeutic role of device‐based neuromodulation in HF.

show abstract

“…Recently, a new transcatheter approach for ventricular reshaping have been developed: the Revivent TC™ System (BioVentrix Inc., San Ramon, CA, USA) (26). Revivent is a hybrid transcatheter/surgical technique in which the LV is reconstructed by plication of the fibrous scar on a beating heart.…”

Section: Left Ventricular Remodelingmentioning

confidence: 99%

“…First of all, a large number of new emerging technologies are under development to treat mitral regurgitation (39) and tricuspid regurgitation (40). The Parachute device (CardioKinetix; Menlo Park, CA, USA) was aimed at treating LV aneurysms by partitioning apical LV aneurysms through a self-expanding endoventricular nitinol device (26). Testing of the Parachute has been abandoned because of the closure of the company.…”

Section: Other Devicesmentioning

confidence: 99%

Innovative transcatheter procedures for the treatment of heart failure

Saia¹,

Loforte²,

Pacini³

2021

Cardiovasc Diagn Ther

View full text Add to dashboard Cite

The prevalence of heart failure (HF) continues to rise over time, with aging of the population and increased survival of incident cases. Major improvements occurred in drug therapy but morbidity and mortality of HF patients remain high. Some non-pharmacologic approaches to HF are already part of standard treatment for HF, including implantable cardioverter-defibrillators, cardiac resynchronization therapy (CRT) and left ventricular assist devices (LVADs). A number of transcatheter treatments and devices have been developed to improve management of valvular heart diseases (VHD), and some of them are being used or tested in specific HF conditions. For example, transcatheter aortic valve implantation (TAVI) to unload the left ventricle in patients with moderate aortic stenosis (AS) and HF or TAVI for severe aortic regurgitation (AR) in patients with LVADs. Similarly, percutaneous mitral valve repair can be used to improve prognosis and quality of life in patients with functional mitral valve regurgitation, and has been proposed as a bridge-to-LVAD or to heart transplant in selected patients. Other devices have been specifically developed for the treatment of chronic HF. In this review we describe the main devices used in the treatment of HF associated with aortic and mitral valve disease, as well as novel transcatheter interventions for chronic HF with different pathophysiologic targets.

show abstract

The last frontier: transcatheter devices for percutaneous or minimally invasive treatment of chronic heart failure

Cited by 9 publications

References 47 publications

Transcatheter Decompression of the Left Atrium in an Adolescent with a Double Inlet Left Ventricle, Severe Parachute Mitral Valve Stenosis and Pulmonary Hypertension

Transcatheter Decompression of the Left Atrium in an Adolescent with a Double Inlet Left Ventricle, Severe Parachute Mitral Valve Stenosis and Pulmonary Hypertension

Neuromodulation interventions in the management of heart failure

Innovative transcatheter procedures for the treatment of heart failure

Contact Info

Product

Resources

About